Leader of the F.D.A. Steps Down After a
Short, Turbulent Tenure
NY Times
By ROBERT PEAR and ANDREW POLLACK
Published: September 24, 2005
WASHINGTON, Sept. 23 - Lester M. Crawford, the commissioner of food and
drugs, resigned abruptly on Friday, causing further upheaval at an agency that
has been in turmoil for over a year.
Dr. Crawford, who was confirmed just two months ago, on July 18, after
serving as acting commissioner for over a year, did not say why he was stepping
down.
Senior officials at the Food and Drug Administration said they were stunned
to learn of the resignation in an e-mail message from Dr. Crawford, who also
sent a letter to President Bush stating that he was resigning "effective
immediately."
Michael O. Leavitt, the secretary of health and human services, accepted the
resignation and thanked Dr. Crawford for his service. Christina Pearson, a
spokeswoman for Mr. Leavitt, refused to say whether Bush administration
officials had asked for the resignation.
"I can't comment," Ms. Pearson said. "This is a personnel issue."
In recent weeks, consumer advocates and scientists inside and outside the
agency had complained that scientific decisions were being warped by
politics.
On Thursday, a commentary in The New England Journal of Medicine titled "A
Sad Day for Science at the F.D.A." said that "recent actions of the F.D.A.
leadership have made a mockery of the process of evaluating scientific
evidence," disillusioned many scientists, "squandered the public trust and
tarnished the agency's image."
Mr. Bush said he intended to name Dr. Andrew C. von Eschenbach, director of
the National Cancer Institute, to be acting commissioner of food and drugs.
Dr. Crawford, a veterinarian and expert on food safety, was named deputy
commissioner of the agency in early 2002 before his tenure as acting
commissioner. In that time the agency has been rocked by disputes over many
issues, including the safety of painkillers like Vioxx, the regulation of heart
defibrillators and other devices, and delays in deciding whether to allow
over-the-counter sales of an emergency contraceptive.
Critics, including members of Congress from both parties, say the agency has
not provided the public with enough information about the risks of drugs and
devices.
"In recent years the F.D.A. has demonstrated a too-cozy relationship with
the pharmaceutical industry and an attitude of shielding rather than disclosing
information," said Senator Charles E. Grassley, Republican of Iowa and chairman
of the Senate Finance Committee.
Senator Barbara A. Mikulski, Democrat of Maryland, said the agency had been
"politicized and degraded" under Dr. Crawford, whose leadership she described
as "tepid and passive."
At the F.D.A., as at the Federal Emergency Management Agency, Ms. Mikulski
said, the Bush administration has brought "incompetent leaders into critical
positions."
Before the Senate confirmed Dr. Crawford, a Senate committee looked into
accusations that he was having an affair with a woman who worked in his office
and that he had wasted government money by taking her on official trips when
she was not needed. An anonymous letter also suggested that Dr. Crawford had
helped the woman secure a promotion to a higher-paying job.
An inquiry by the inspector general of the Department of Health and Human
Services found some contradictions in statements by Dr. Crawford and the woman.
Investigators found a close personal relationship between them but no evidence
of an extramarital affair.
The committee chairman, Senator Michael B. Enzi, Republican of Wyoming, said
at the time that the inspector general had found no merit to the charges
leveled at Dr. Crawford. No senator wanted to pursue the issue further.
|